Nonpenetrating very deep Sclerectomy with hyaluronic acid implant vs trabeculectomy

Nonpenetrating very deep sclerectomy with hyaluronic acid implant vs trabeculectomy — a 2-year follow-up. A Prospective, controlled, Clinical study

Article specifications

This clinical trial was published in 2012 in Graefe's Archive for Clinical and Experimental Ophthalmology (IF 2016:2.349) by Polish ophthalmologists.

In this article the efficacy and safety of nonpenetrating very deep sclerectomy (NPVDS) with the use of hyaluronic acid implant (SKGEL) was compared with trabeculectomy (TB) in patients with medically uncontrolled glaucoma.

78 eyes of 68 patients with patients with medically uncontrolled glaucoma were assigned either to the NPVDS or to the TB group of trial. Examinations were applied before and 7 days, 1, 3, 6, 12, 18, and 24 months after surgery.

Results

The results of the study showed that NPVDS with hyaluronic acid is an effective surgical option for medically uncontrolled glaucoma, NPVDS with hyaluronic acid also have a lower risk of complications, and in particular cataract progression, compared to TB.